Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic. Two doses of an inactivated SARS-CoV-2 vaccine (CoronaVac) have been shown to be insufficient to protect against variants of concern (VOCs), while viral vector vaccines remain protective against the infection....

Descripción completa

Detalles Bibliográficos
Autores principales: Pinpathomrat, Nawamin, Intapiboon, Porntip, Seepathomnarong, Purilap, Ongarj, Jomkwan, Sophonmanee, Ratchanon, Hengprakop, Jariya, Surasombatpattana, Smonrapat, Uppanisakorn, Supattra, Mahasirimongkol, Surakameth, Sawaengdee, Waritta, Phumiamorn, Supaporn, Sapsutthipas, Sompong, Kongkamol, Chanon, Ingviya, Thammasin, Sangsupawanich, Pasuree, Chusri, Sarunyou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106663/
https://www.ncbi.nlm.nih.gov/pubmed/35562372
http://dx.doi.org/10.1038/s41541-022-00475-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106663/
https://www.ncbi.nlm.nih.gov/pubmed/35562372
http://dx.doi.org/10.1038/s41541-022-00475-z

Ejemplares similares